Literature DB >> 11561046

Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression.

M García-Toro1, A Pascual-Leone, M Romera, A González, J Micó, O Ibarra, H Arnillas, I Capllonch, A Mayol, J M Tormos.   

Abstract

A growing number of studies report antidepressant effects of repetitive transcranial magnetic stimulation (rTMS) in patients with major depression. The hypothesis that high frequency (20 Hz) rTMS (HF-rTMS) may speed up and strengthen the therapeutic response to sertraline in MD was tested. Twenty eight patients who had not yet received medication for the present depressive episode (n=12) or had failed a single trial of an antidepressant medication (n=16) were started on sertraline and randomised to receive either real of sham HF-rTMS. HF-rTMS was applied to the left dorsolateral prefrontal area in daily sessions (30 trains of 2 s, 20-40 s intertrain interval, at 90% motor threshold) on 10 consecutive working days. The results suggest that in this patient population, HF-rTMS does not add efficacy over the use of standard antidepressant medication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561046      PMCID: PMC1763496          DOI: 10.1136/jnnp.71.4.546

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?

Authors:  Biju Basil; Jamal Mahmud; Maju Mathews; Carlos Rodriguez; Babatunde Adetunji
Journal:  Psychiatry (Edgmont)       Date:  2005-11

Review 2.  Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis.

Authors:  Jennifer L Couturier
Journal:  J Psychiatry Neurosci       Date:  2005-03       Impact factor: 6.186

3.  Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-06-01

Review 4.  Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?

Authors:  Frank Padberg; Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

5.  Short-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in depression- reanalysis of data from meta-analyses up to 2010.

Authors:  Karina Karolina Kedzior; Sarah Kim Reitz
Journal:  BMC Psychol       Date:  2014-10-07

6.  More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013.

Authors:  Karina Karolina Kedzior; Valeriya Azorina; Sarah Kim Reitz
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-07       Impact factor: 2.570

7.  Less Might Be More: Conduction Failure as a Factor Possibly Limiting the Efficacy of Higher Frequencies in rTMS Protocols.

Authors:  Islam Halawa; Amir Goldental; Yuichiro Shirota; Ido Kanter; Walter Paulus
Journal:  Front Neurosci       Date:  2018-05-28       Impact factor: 4.677

8.  Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis.

Authors:  Helena M Gellersen; Karina Karolina Kedzior
Journal:  BMC Psychiatry       Date:  2019-05-07       Impact factor: 3.630

Review 9.  Transcranial magnetic stimulation for treating depression.

Authors:  J L Martin; M J Barbanoj; T E Schlaepfer; S Clos; V Perez; J Kulisevsky; A Gironell
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 10.  Meta-analysis of the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.

Authors:  Yanyan Wei; Junjuan Zhu; Shengke Pan; Hui Su; Hui Li; Jijun Wang
Journal:  Shanghai Arch Psychiatry       Date:  2017-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.